+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction



Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction



Japanese Circulation Journal 62(3): 183-189



This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction. Seventy patients were treated with placebo or nicorandil concomitant with reperfusion therapy in a prospective, randomized, double-blind fashion within 6 h after the onset of acute myocardial infarction. Nicorandil was administered before reperfusion as a 2-mg bolus iv injection followed by continuous infusion of 2-6 mg/h for the next 3 h. Thirty-six patients (17 in the placebo group, 19 in the nicorandil group) who demonstrated both complete occlusion of an infarct-related vessel before treatment and successful reperfusion were included in the final analysis. No significant changes in left ventricular ejection fraction were observed between the immediate and chronic phases in each group. In the analysis of regional ventricular function, the placebo group did not show any significant change in regional chord shortening (26.8+/-8.2 vs 24.3+/-7.3%, NS) or hypocontractile perimeter (36.4+/-28.2% vs 28.3+/-24.8%, NS) between immediate and chronic phase left ventriculograms. In contrast, in the nicorandil group, a significant increase in regional chord shortening (21.5+/-11.0% vs 25.8+/-11.3%, p<0.05) and a significant decrease in hypocontractile perimeter (33.3+/-19.6% vs 25.6+/-24.3%, p<0.05) were observed in the chronic phase left ventriculogram. Thus, nicorandil may be a useful adjunctive therapy for preserving myocardial contractile function in patients with acute myocardial infarction undergoing reperfusion therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008266173

Download citation: RISBibTeXText

PMID: 9583444

DOI: 10.1253/jcj.62.183


Related references

Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia. Diabetes Care 29(2): 202-206, 2006

Intravenous nicorandil before reperfusion prevents left ventricular remodeling in patients with acute myocardial infarction. 2007

Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circulation Journal 67(4): 295-300, 2003

Intravenous K channel opener, nicorandil, accelerates microvascular reperfusion and improves clinical outcomes in patients with acute myocardial infarction. Circulation 100(18 Suppl. ): I 303, 1999

Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction. Canadian Journal of Cardiology 20(6): 625-629, 2004

The impact of intravenous nicorandil before reperfusion for patients of myocardial infarction. Circulation 108(17 Suppl.): IV-418, 2003

Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction. Journal of Cardiology 49(3): 135-141, 2007

Can cardioprotective effect of nicorandil administration be influenced by the grade of TIMI flow and collateral flow in patients with acute myocardial infarction?. Journal of Nuclear Medicine 43(5 Suppl.): 182P, 2002

Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112(9): 1284-1288, 2005

Cardioprotective effect of nicorandil administration on lately reperfused acute myocardial infarction Using 99mTc-tetrofosmin and 123I-BMIPP imagings. Journal of Nuclear Medicine 43(5 Suppl.): 180P, 2002

Cardioprotective effect of nicorandil as an adjunct to primary PTCA for acute myocardial infarction compared with magnesium A prospective randomized trial. Circulation 100(18 Suppl. ): I 284, 1999

Microvascular protection with intravenous nicorandil augments myocardial salvage in patients with acute myocardial infarction. Journal of the American College of Cardiology 29(2 Suppl. A): 134A, 1997

Intravenous nicorandil augments microvascular and myocardial salvage and reduces complications in patients with acute myocardial infarction. Circulation 96(8 Suppl. ): I748, 10/21/97, 1997

Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction. American Journal of Cardiology 99(9): 1203-1207, 2007

Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction. Nuclear Medicine Communications 29(11): 956-962, 2008